New PET tracer aims to spot hidden inflammation in cancer and heart disease
NCT ID NCT04758650
First seen Jun 04, 2026 · Last updated Jun 12, 2026 · Updated 2 times
Summary
This study tested a special imaging agent (68GaNOTA-anti-MMR-VHH2) that uses PET scans to find certain immune cells (macrophages) in the body. It included 29 adults with head and neck cancer, atherosclerosis, lymphoma, or sarcoidosis. The goal was to see if this scan could help predict treatment response or confirm disease presence, but the study was terminated early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Uz Brussel
Brussels, Brussels Capital, 1090, Belgium
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.